Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ROIVW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.23
N/A
NA
vs -0.00
Q1.24
N/A
NA
vs -0.00
Q2.24
N/A
NA
vs -0.00
Q3.24
N/A
NA
vs NA
Q4.24
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.23
+118%
37.1M vs 17.1M
Q1.24
+6%
28.9M vs 27.4M
Q2.24
+155%
55.1M vs 21.6M
Q3.24
-88%
4.5M vs 37.1M
Q4.24
-76%
9M vs 37.1M
Return on Equity
QoQ
Q1.23
-3%
-0.03
vs -0.37
Q2.23
-32%
-0.32
vs -0.03
Q3.23
-32%
-0.32
vs -0.32
Q4.23
+84%
0.84
vs -0.32
Q1.24
-3%
-0.03
vs 0.84
Q2.24
+2%
0.02
vs -0.03
Q3.24
-4%
-0.04
vs 0.02
Q4.24
+3%
0.03
vs -0.04
Institutionnal Ownership
QoQ
Q4.21
41
41
vs NA
NA
Q1.22
38
38
vs 41
-7%
Q2.22
33
33
vs 38
-13%
Q3.22
32
32
vs 33
-3%
Q4.22
31
31
vs 32
-3%
Q1.23
25
25
vs 31
-19%
Q2.23
29
29
vs 25
16%
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
NASDAQ
0.12Â ( 4.56%)
Relative Strenght
98
Volume Buzz
0%
Earning Acce
No
Dist 52w H.
4%Relative Strength
ROIVW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics